CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation
Lysine acetylation is becoming increasingly recognized as a general biological principle in cellular homeostasis, and is subject to abnormal control in different human pathologies. Here, we describe a global effect on amyloid-like protein aggregation in human cells that results from aberrant lysine...
Main Authors: | Olzscha, H, Fedorov, O, Kessler, B, Knapp, S, La Thangue, N |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
Cell Press
2016
|
Lignende værker
-
Bromodomains control amyloid-like aggregation of aberrantly acetylated proteins
af: Olzscha, H, et al.
Udgivet: (2018) -
Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
af: Popp, T, et al.
Udgivet: (2016) -
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
af: Hay, D, et al.
Udgivet: (2014) -
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
af: Picaud, S, et al.
Udgivet: (2015) -
Targeting bromodomains: epigenetic readers of lysine acetylation.
af: Filippakopoulos, P, et al.
Udgivet: (2014)